Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Strong Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/10/1987

Market Cap

84,220,326,600

Shares Outstanding

4,115,080,000

Weighted SO

2,057,538,907

Total Employees

N/A

Upcoming Earnings

07/31/2024

Similar Tickers

NVS --.--%

AZN --.--%

RHHBY --.--%

BMY --.--%

AMGN --.--%

MRK --.--%

ABBV --.--%

GILD --.--%

JNJ --.--%

Beta

0.2930

Last Div

1.5300

Range

33.67-45.93

Chg

0.2807

Avg Vol

3715164

Mkt Cap

84220326600

Exch

NYSE

Country

GB

Phone

44 20 8047 5000

DCF Diff

3.0128

DCF

38.2522

Div Yield

0.0451

P/S

2.0716

EV Multiple

7.9618

P/FV

9.0654

Div Yield %

4.5077

P/E

32.3056

PEG

0.3231

Payout

0.5839

Current Ratio

0.8240

Quick Ratio

0.5360

Cash Ratio

0.1456

DSO

90.2808

DIO

247.8599

Op Cycle

338.1407

DPO

602.6223

CCC

-264.4816

Gross Margin

0.7256

Op Margin

0.2216

Pretax Margin

0.1597

Net Margin

0.1283

Eff Tax Rate

0.1400

ROA

0.0695

ROE

0.2950

ROCE

0.1848

NI/EBT

0.8029

EBT/EBIT

0.7208

EBIT/Rev

0.2216

Debt Ratio

0.2918

D/E

1.1789

LT Debt/Cap

0.4858

Total Debt/Cap

0.5411

Int Coverage

9.3669

CF/Debt

0.4134

Equity Multi

4.0402

Rec Turnover

4.0429

Pay Turnover

0.6057

Inv Turnover

1.4726

FA Turnover

3.2013

Asset Turnover

0.5416

OCF/Share

1.7171

FCF/Share

1.1569

Cash/Share

0.7313

OCF/Sales

0.2227

FCF/OCF

0.6738

CF Coverage

0.4134

ST Coverage

2.0808

CapEx Coverage

3.0652

Div&CapEx Cov

1.5095

P/BV

9.0654

P/B

9.0654

P/S

2.0716

P/E

32.3056

P/FCF

13.8045

P/OCF

18.6020

P/CF

18.6020

PEG

0.3231

P/S

2.0716

EV Multiple

7.9618

P/FV

9.0654

DPS

1.8615

Latest Headlines (EST)

GlobeNewswire Inc. Apr 05, 20:44 GSK DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages GSK plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – GSK GlobeNewswire Inc. Apr 03, 22:13 Anne Whitaker Appointed as Non-Executive Director GlobeNewswire Inc. Mar 10, 00:30 Global Prostate Cancer Market to Reach USD 29.2 Billion by 2035, Driven by Aging Population and Awareness | Future Market Insights, Inc. GlobeNewswire Inc. Feb 23, 03:51 ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK GlobeNewswire Inc. Feb 19, 23:32 ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK GlobeNewswire Inc. Feb 16, 23:55 ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK GlobeNewswire Inc. Feb 14, 01:47 ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK GlobeNewswire Inc. Feb 07, 00:48 GSK PLC Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against GSK GlobeNewswire Inc. Oct 16, 05:00 Bioversys Announces Last Patient Last Visit in BV100 Phase 2 Clinical Trial in Ventilator Associated Bacterial Pneumonia (VABP) and Provides a Business Update The Motley Fool Oct 09, 22:39 Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday GlobeNewswire Inc. Sep 15, 02:41 iTeos annonce un taux de réponse objective cliniquement significatif observé à chaque dose lors de l’analyse intermédiaire de suivi de l’étude GALAXIES Lung-201 portant sur l’association belrestotug + dostarlimab dans le traitement de première ligne des p GlobeNewswire Inc. Sep 13, 00:15 Nicotine Replacement Products Market Size to Reach USD 4.6 Billion by 2033, Says The Brainy Insights GlobeNewswire Inc. Aug 27, 02:48 Simtra BioPharma Solutions ernennt Dr. Lidia Serina zum Head of Development Services GlobeNewswire Inc. Aug 12, 21:00 Monoclonal Antibodies Market Size is Surpassing USD 650.49 Billion by 2033, Growing at Projected 12.0% CAGR GlobeNewswire Inc. Jul 03, 05:00 Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewswire MarketWatch Jan 22, 10:04 Gilead’s stock tumbles toward biggest selloff in more than nine years as lung-cancer trial disappoints MarketWatch Jan 20, 14:00 Take that, Wall Street! Pariah Capital wins again — and the picks for 2024 MarketWatch Jan 20, 14:00 Take that, Wall Street! Pariah Capital wins again — and the picks for 2024 MarketWatch Jan 20, 14:00 Take that, Wall Street! Pariah Capital wins again — and the picks for 2024 MarketWatch Jan 20, 14:00 Take that, Wall Street! Pariah Capital wins again — and the picks for 2024

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.38 05/16/2024 05/01/2024 05/17/2024 07/11/2024
0.41 02/22/2024 02/01/2024 02/23/2024 04/11/2024
0.34 11/16/2023 11/01/2023 11/17/2023 01/11/2024
0.36 08/17/2023 07/26/2023 08/18/2023 10/12/2023
0.35 05/18/2023 04/26/2023 05/19/2023 07/13/2023
0.33 02/23/2023 02/01/2023 02/24/2023 04/13/2023
0.37 11/17/2022 11/02/2022 11/18/2022 01/12/2023
0.38 08/18/2022 07/27/2022 08/19/2022 10/06/2022
0.28 05/19/2022 05/02/2022 05/20/2022 07/01/2022
0.50 02/24/2022 02/09/2022 02/25/2022 04/07/2022
0.42 11/18/2021 10/28/2021 11/19/2021 01/13/2022
0.42 08/19/2021 07/30/2021 08/20/2021 10/07/2021
0.42 05/20/2021 05/04/2021 05/21/2021 07/08/2021
0.50 02/18/2021 02/04/2021 02/19/2021 04/08/2021
0.40 11/12/2020 10/29/2020 11/13/2020 01/14/2021
0.39 08/13/2020 07/29/2020 08/14/2020 10/08/2020
0.38 05/14/2020 04/29/2020 05/15/2020 07/09/2020
0.48 02/20/2020 02/05/2020 02/21/2020 04/09/2020
0.39 11/14/2019 11/30/-0001 11/15/2019 01/09/2020
0.37 08/08/2019 11/30/-0001 08/09/2019 10/10/2019
0.40 05/16/2019 05/03/2019 05/17/2019 07/11/2019
0.48 02/21/2019 02/07/2019 02/22/2019 04/11/2019
0.39 11/15/2018 11/01/2018 11/16/2018 01/10/2019
0.40 08/09/2018 07/25/2018 08/10/2018 10/11/2018
0.42 05/10/2018 04/26/2018 05/11/2018 07/12/2018
0.51 02/22/2018 02/07/2018 02/23/2018 04/12/2018
0.40 11/09/2017 10/25/2017 11/10/2017 01/11/2018
0.40 08/09/2017 07/26/2017 08/11/2017 10/12/2017
0.39 05/10/2017 04/26/2017 05/12/2017 07/13/2017
0.46 02/22/2017 02/08/2017 02/24/2017 04/13/2017
0.37 11/02/2016 10/26/2016 11/04/2016 01/12/2017
0.40 08/10/2016 07/27/2016 08/12/2016 10/13/2016
0.44 05/11/2016 04/28/2016 05/13/2016 07/14/2016
1.00 02/17/2016 11/30/-0001 11/30/-0001 04/14/2016
0.47 11/10/2015 10/28/2015 11/13/2015 01/14/2016
0.47 08/12/2015 11/30/-0001 11/30/-0001 10/01/2015
0.46 05/13/2015 05/07/2015 05/15/2015 07/09/2015
0.56 02/18/2015 02/04/2015 02/20/2015 04/09/2015
0.49 11/05/2014 10/22/2014 11/07/2014 01/08/2015
0.52 08/06/2014 07/23/2014 08/08/2014 10/02/2014
0.51 05/14/2014 04/30/2014 05/16/2014 07/10/2014
0.60 02/19/2014 02/05/2014 02/21/2014 04/10/2014
0.49 11/13/2013 10/23/2013 11/15/2013 01/09/2014
0.44 08/07/2013 07/24/2013 08/09/2013 10/03/2013
0.44 05/08/2013 04/24/2013 05/10/2013 07/11/2013
0.55 02/20/2013 02/06/2013 02/22/2013 04/11/2013
0.46 11/14/2012 10/31/2012 11/30/-0001 01/03/2013
0.42 08/08/2012 07/25/2012 11/30/-0001 10/04/2012
0.44 05/09/2012 04/25/2012 11/30/-0001 07/05/2012
0.66 02/15/2012 02/07/2012 11/30/-0001 04/12/2012
0.43 11/02/2011 10/26/2011 11/30/-0001 01/05/2012
0.42 08/03/2011 07/26/2011 11/30/-0001 10/06/2011
0.42 05/04/2011 04/27/2011 11/30/-0001 07/07/2011
0.49 02/09/2011 02/03/2011 11/30/-0001 04/07/2011
0.41 10/27/2010 10/21/2010 11/30/-0001 01/06/2011
0.37 07/28/2010 07/22/2010 11/30/-0001 10/07/2010
0.37 05/05/2010 04/28/2010 11/30/-0001 07/08/2010
0.46 02/10/2010 02/04/2010 11/30/-0001 04/08/2010
0.39 11/04/2009 10/28/2009 11/30/-0001 01/07/2010
0.37 07/29/2009 07/22/2009 11/30/-0001 10/08/2009
0.33 04/29/2009 11/30/-0001 11/30/-0001 11/30/-0001
0.40 02/11/2009 11/30/-0001 11/30/-0001 11/30/-0001
0.38 10/29/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.42 07/30/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.42 04/30/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.50 02/13/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.43 10/31/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.40 08/01/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.38 05/02/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.44 02/14/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.36 11/01/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.32 08/02/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.31 05/10/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.39 02/15/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.28 11/02/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.28 08/03/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.30 05/11/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.36 02/16/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.29 11/03/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.29 08/04/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.28 05/12/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.42 02/18/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.24 10/29/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.23 07/30/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.25 05/07/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.37 02/19/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.25 10/30/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.25 07/31/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.44 05/01/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.57 02/20/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.23 10/31/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.23 08/01/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.23 05/02/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.59 12/27/2000 11/30/-0001 11/30/-0001 11/30/-0001
0.40 08/09/2000 11/30/-0001 11/30/-0001 11/30/-0001
0.63 03/01/2000 11/30/-0001 11/30/-0001 11/30/-0001
0.43 08/11/1999 11/30/-0001 11/30/-0001 11/30/-0001
0.48 03/03/1999 11/30/-0001 11/30/-0001 11/30/-0001
0.40 08/12/1998 11/30/-0001 11/30/-0001 11/30/-0001
0.52 03/04/1998 11/30/-0001 11/30/-0001 11/30/-0001
0.39 08/13/1997 11/30/-0001 11/30/-0001 11/30/-0001
0.58 03/19/1997 11/30/-0001 11/30/-0001 11/30/-0001
0.47 08/16/1996 11/30/-0001 11/30/-0001 11/30/-0001
0.46 03/22/1996 11/30/-0001 11/30/-0001 11/30/-0001
0.62 09/22/1995 11/30/-0001 11/30/-0001 11/30/-0001
0.31 02/24/1995 11/30/-0001 11/30/-0001 11/30/-0001
0.56 09/23/1994 11/30/-0001 11/30/-0001 11/30/-0001
0.27 03/14/1994 11/30/-0001 11/30/-0001 11/30/-0001
0.05 09/24/1993 11/30/-0001 11/30/-0001 11/30/-0001
0.29 03/05/1993 11/30/-0001 11/30/-0001 11/30/-0001
0.48 09/21/1992 11/30/-0001 11/30/-0001 11/30/-0001
0.22 02/28/1992 11/30/-0001 11/30/-0001 11/30/-0001
0.61 09/16/1991 11/30/-0001 11/30/-0001 11/30/-0001
0.29 03/15/1991 11/30/-0001 11/30/-0001 11/30/-0001
0.42 09/24/1990 11/30/-0001 11/30/-0001 11/30/-0001
0.24 03/30/1990 11/30/-0001 11/30/-0001 11/30/-0001
0.28 10/05/1989 11/30/-0001 11/30/-0001 11/30/-0001
0.12 04/07/1989 11/30/-0001 11/30/-0001 11/30/-0001
0.10 11/18/1988 11/30/-0001 11/30/-0001 11/30/-0001
0.09 04/18/1988 11/30/-0001 11/30/-0001 11/30/-0001
0.19 11/20/1987 11/30/-0001 11/30/-0001 11/30/-0001
0.06 05/15/1987 11/30/-0001 11/30/-0001 11/30/-0001